Detalles de la búsqueda
1.
Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors.
Cell
; 156(4): 744-58, 2014 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-24529377
2.
Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8+ regulatory T cells.
Proc Natl Acad Sci U S A
; 118(21)2021 05 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34006646
3.
A single-step, rapid, and versatile method for simultaneous detection of cell surface glycan profiles using fluorochrome-conjugated lectins.
Glycobiology
; 33(11): 855-860, 2023 Dec 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37584473
4.
Reprogramming the tumor metastasis cascade by targeting galectin-driven networks.
Biochem J
; 478(3): 597-617, 2021 02 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33600595
5.
Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10.
Nat Immunol
; 10(9): 981-91, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19668220
6.
Differential response of myeloid-derived suppressor cells to the nonsteroidal anti-inflammatory agent indomethacin in tumor-associated and tumor-free microenvironments.
J Immunol
; 194(7): 3452-62, 2015 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25740944
7.
Expansion of CD11b(+)Ly6G (+)Ly6C (int) cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions.
Cancer Immunol Immunother
; 62(12): 1781-95, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24114144
8.
Neuroblastoma triggers an immunoevasive program involving galectin-1-dependent modulation of T cell and dendritic cell compartments.
Int J Cancer
; 131(5): 1131-41, 2012 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22020795
9.
The aggressiveness of murine lymphomas selected in vivo by growth rate correlates with galectin-1 expression and response to cyclophosphamide.
Cancer Immunol Immunother
; 61(4): 469-80, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21947259
10.
Untangling Galectin-Mediated Circuits that Control Hypoxia-Driven Angiogenesis.
Methods Mol Biol
; 2442: 635-653, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35320550
11.
Enhanced Antitumor Immunity via Endocrine Therapy Prevents Mammary Tumor Relapse and Increases Immune Checkpoint Blockade Sensitivity.
Cancer Res
; 81(5): 1375-1387, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33268529
12.
Dissecting the signal transduction pathways triggered by galectin-glycan interactions in physiological and pathological settings.
IUBMB Life
; 62(1): 1-13, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20014236
13.
Dissecting the pathophysiologic role of endogenous lectins: glycan-binding proteins with cytokine-like activity?
Cytokine Growth Factor Rev
; 18(1-2): 57-71, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17321195
14.
Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression.
J Exp Med
; 217(2)2020 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31873723
15.
Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells.
Mol Cell Biol
; 25(12): 4826-40, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15923602
16.
Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.
Mol Endocrinol
; 21(6): 1335-58, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17440047
17.
Glycans Pave the Way for Immunotherapy in Triple-Negative Breast Cancer.
Cancer Cell
; 33(2): 155-157, 2018 02 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29438689
18.
Correction: Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells.
Oncogene
; 42(41): 3087, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37684409
19.
Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells.
Mol Cell Biol
; 23(3): 1095-111, 2003 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-12529413
20.
Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
Oncogene
; 23(30): 5161-74, 2004 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15122317